{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:42:35Z","timestamp":1781599355338,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["Deutsche Forschungsgemeinschaft SI-1281\/5-1 (CS)"],"award-info":[{"award-number":["Deutsche Forschungsgemeinschaft SI-1281\/5-1 (CS)"]}],"id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Medicine and Pharmacy ''Iuliu Hatieganu'', Cluj-Napoca, Romania","award":["4945\/6\/08.03.2016 (SD)"],"award-info":[{"award-number":["4945\/6\/08.03.2016 (SD)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0855-x","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T07:44:06Z","timestamp":1530863046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid"],"prefix":"10.1186","volume":"13","author":[{"given":"Roxana","family":"Chiorean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Danescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Virtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayson B.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lischka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-1270","authenticated-orcid":false,"given":"Cassian","family":"Sitaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"855_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/15665240113136660079","volume":"14","author":"JV Otten","year":"2014","unstructured":"Otten JV, Hashimoto T, Hertl M, Payne AS, Sitaru C. Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med. 2014;14:69\u201395.","journal-title":"Curr Mol Med"},{"key":"855_CR2","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370\u20139.","journal-title":"Arch Dermatol"},{"key":"855_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.autrev.2015.06.005","volume":"14","author":"MB Mustafa","year":"2015","unstructured":"Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015;14:930\u201351.","journal-title":"Autoimmun Rev"},{"key":"855_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0190-9622(80)80111-3","volume":"3","author":"R Hanno","year":"1980","unstructured":"Hanno R, Foster DR, Bean SF. Brunsting-Perry cicatricial pemphigoid associated with bullous pemphigoid. J Am Acad Dermatol. 1980;3:470\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"855_CR5","first-page":"1019","volume":"55","author":"R Chiorean","year":"2014","unstructured":"Chiorean R, Mahler M, Sitaru C. Molecular diagnosis of autoimmune skin diseases. Romanian J Morphol Embryol. 2014;55:1019\u201333.","journal-title":"Romanian J Morphol Embryol"},{"key":"855_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1582-4934.2007.00033.x","volume":"11","author":"S Mihai","year":"2007","unstructured":"Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11:462\u201381.","journal-title":"J Cell Mol Med"},{"key":"855_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1172\/JCI116033","volume":"90","author":"N Domloge-Hultsch","year":"1992","unstructured":"Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest. 1992;90:1628\u201333.","journal-title":"J Clin Invest"},{"key":"855_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/1523-1747.ep12616797","volume":"99","author":"P Bernard","year":"1992","unstructured":"Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JH. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol. 1992;99:174\u20139.","journal-title":"J Invest Dermatol."},{"key":"855_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","volume":"106","author":"SD Balding","year":"1996","unstructured":"Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol. 1996;106:141\u20136.","journal-title":"J Invest Dermatol."},{"key":"855_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","volume":"145","author":"E Schmidt","year":"2001","unstructured":"Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Br\u00f6cker EB, et al. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol. 2001;145:778\u201383.","journal-title":"Br J Dermatol"},{"key":"855_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","volume":"17","author":"H Murakami","year":"1998","unstructured":"Murakami H, Nishioka S, Setterfield J, Bhogal BS, Black MM, Zillikens D, et al. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci. 1998;17:39\u201344.","journal-title":"J Dermatol Sci"},{"key":"855_CR12","doi-asserted-by":"publisher","first-page":"14714","DOI":"10.1073\/pnas.93.25.14714","volume":"93","author":"S Tyagi","year":"1996","unstructured":"Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A. 1996;93:14714\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"855_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2133.1997.18191915.x","volume":"137","author":"F Caux","year":"1997","unstructured":"Caux F, Kirtschig G, Lemarchand-Venencie F, Venencie PY, Hoang-Xuan T, Robin H, et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol. 1997;137:270\u20135.","journal-title":"Br J Dermatol"},{"key":"855_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000018139","volume":"198","author":"N Wieme","year":"1999","unstructured":"Wieme N, Lambert J, Moerman M, Geerts ML, Temmerman L, Naeyaert JM. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. Dermatology (Basel). 1999;198:310\u20133.","journal-title":"Dermatology (Basel)"},{"key":"855_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1172\/JCI118942","volume":"98","author":"Z Lazarova","year":"1996","unstructured":"Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest. 1996;98:1509\u201318.","journal-title":"J Clin Invest"},{"key":"855_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/clim.2000.4845","volume":"95","author":"Z Lazarova","year":"2000","unstructured":"Lazarova Z, Hsu R, Briggaman RA, Yancey KB. Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice. Clin Immunol. 2000;95:26\u201332.","journal-title":"Clin Immunol"},{"key":"855_CR17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","volume":"357","author":"CA Egan","year":"2001","unstructured":"Egan CA, Lazarova Z, Darling TN, Yee C, Cot\u00e9 T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001;357:1850\u20131.","journal-title":"Lancet"},{"key":"855_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2016.07.021","volume":"170","author":"F Florea","year":"2016","unstructured":"Florea F, Koch M, Hashimoto T, Sitaru C. Autoimmunity against laminins. Clin Immunol. 2016;170:39\u201352.","journal-title":"Clin Immunol"},{"key":"855_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","volume":"58","author":"Z Lazarova","year":"2008","unstructured":"Lazarova Z, Salato VK, Lanschuetzer CM, Janson M, Fairley JA, Yancey KB. IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid. J Am Acad Dermatol. 2008;58:951\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"855_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1600-0625.2008.00721.x","volume":"17","author":"K Sugawara","year":"2008","unstructured":"Sugawara K, Tsuruta D, Ishii M, Jones JCR, Kobayashi H. Laminin-332 and -511 in skin. Exp Dermatol. 2008;17:473\u201380.","journal-title":"Exp Dermatol"},{"key":"855_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/1523-1747.ep12323431","volume":"105","author":"G Kirtschig","year":"1995","unstructured":"Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol. 1995;105:543\u20138.","journal-title":"J Invest Dermatol."},{"key":"855_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/1523-1747.ep12665840","volume":"104","author":"H Shimizu","year":"1995","unstructured":"Shimizu H, Masunaga T, Ishiko A, Matsumura K, Hashimoto T, Nishikawa T, et al. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. J Invest Dermatol. 1995;104:370\u20133.","journal-title":"J Invest Dermatol."},{"key":"855_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0923-1811(03)00158-0","volume":"33","author":"Y Hisamatsu","year":"2003","unstructured":"Hisamatsu Y, Nishiyama T, Amano S, Matsui C, Ghohestani R, Hashimoto T. Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti-laminin 5 cicatricial pemphigoid. J Dermatol Sci. 2003;33:113\u20139.","journal-title":"J Dermatol Sci"},{"key":"855_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","volume":"51","author":"Z Lazarova","year":"2004","unstructured":"Lazarova Z, Sitaru C, Zillikens D, Yancey KB. Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol. 2004;51:886\u201392.","journal-title":"J Am Acad Dermatol"},{"key":"855_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1001\/archderm.1994.01690120057008","volume":"130","author":"N Domloge-Hultsch","year":"1994","unstructured":"Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder Arch Dermatol. 1994;130:1521\u20139.","journal-title":"A subepithelial bullous disorder Arch Dermatol"},{"key":"855_CR26","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0190-9622(96)90086-9","volume":"34","author":"T Hashimoto","year":"1996","unstructured":"Hashimoto T, Murakami H, Senboshi Y, Kanzaki H, Arata J, Yancey KB, et al. Antiepiligrin cicatricial pemphigoid: the first case report from Japan. J Am Acad Dermatol. 1996;34:940\u20132.","journal-title":"J Am Acad Dermatol"},{"key":"855_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/1523-1747.ep12337073","volume":"109","author":"R Hsu","year":"1997","unstructured":"Hsu R, Lazarova Z, Yee C, Yancey KB. Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid. J Invest Dermatol. 1997;109:557\u201361.","journal-title":"J Invest Dermatol"},{"key":"855_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","volume":"124","author":"V Bekou","year":"2005","unstructured":"Bekou V, Thoma-Uszynski S, Wendler O, Uter W, Schwietzke S, Hunziker T, et al. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol. 2005;124:732\u201340.","journal-title":"J Invest Dermatol."},{"key":"855_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","volume":"149","author":"P Bernard","year":"2013","unstructured":"Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, et al. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol. 2013;149:533\u201340.","journal-title":"JAMA Dermatol"},{"key":"855_CR30","first-page":"713","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt E, Goebeler M, Hertl M, S\u00e1rdy M, Sitaru C, Eming R, et al. S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2015;13:713\u201327.","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"855_CR31","first-page":"33036","volume":"283","author":"Y Kariya","year":"2008","unstructured":"Kariya Y, Kato R, Itoh S, Fukuda T, Shibukawa Y, Sanzen N, et al. N-glycosylation of Laminin-332 regulates its biological functions. a novel function of the bisecting GlcNAc J Biol Chem. 2008;283:33036\u201345.","journal-title":"a novel function of the bisecting GlcNAc J Biol Chem"},{"key":"855_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","volume":"118","author":"C Sitaru","year":"2002","unstructured":"Sitaru C, Schmidt E, Petermann S, Munteanu LS, Br\u00f6cker E-B, Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal\u2013epidermal separation in Cryosections of human skin. J Invest Dermatol. 2002;118:664\u201371.","journal-title":"J Invest Dermatol."},{"key":"855_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","volume":"30","author":"M Kobayashi","year":"2002","unstructured":"Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci. 2002;30:224\u201332.","journal-title":"J Dermatol Sci"},{"key":"855_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-6-31","volume":"6","author":"K Csorba","year":"2011","unstructured":"Csorba K, Schmidt S, Florea F, Ishii N, Hashimoto T, Hertl M, et al. Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis. 2011;6:31.","journal-title":"Orphanet J Rare Dis"},{"key":"855_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2172-13-16","volume":"13","author":"E Licarete","year":"2012","unstructured":"Licarete E, Ganz S, Recknagel MJ, Di Zenzo G, Hashimoto T, Hertl M, et al. Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. BMC Immunol. 2012;13:16.","journal-title":"BMC Immunol"},{"key":"855_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jdermsci.2014.12.003","volume":"77","author":"X Li","year":"2015","unstructured":"Li X, Qian H, Takizawa M, Koga H, Tsuchisaka A, Ishii N, et al. N-linked glycosylation on laminin \u03b31 influences recognition of anti-laminin \u03b31 pemphigoid autoantibodies. J Dermatol Sci. 2015;77:125\u20139.","journal-title":"J Dermatol Sci"},{"key":"855_CR37","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/jid.2008.132","volume":"128","author":"EP Zimina","year":"2008","unstructured":"Zimina EP, Hofmann SC, Fritsch A, Kern JS, Sitaru C, Bruckner-Tuderman L. Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII. J Invest Dermatol. 2008;128:2736\u20139.","journal-title":"J Invest Dermatol."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0855-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T17:43:04Z","timestamp":1569001384000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0855-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0855-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"25 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Ethic Committee from the University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d from Cluj-Napoca, Romania and performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"111"}}